159 related articles for article (PubMed ID: 21225916)
1. Kaposi sarcoma in South African children.
Stefan DC; Stones DK; Wainwright L; Newton R
Pediatr Blood Cancer; 2011 Mar; 56(3):392-6. PubMed ID: 21225916
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Stein ME; Lachter J; Spencer D; Bezwoda WR
Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
4. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
5. Raynaud's phenomenon and digital gangrene as a consequence of treatment for Kaposi's sarcoma.
Hladunewich M; Sawka C; Fam A; Franssen E
J Rheumatol; 1997 Dec; 24(12):2371-5. PubMed ID: 9415644
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
Mani D; Neil N; Israel R; Aboulafia DM
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(5):279-85. PubMed ID: 19721098
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load.
Maurer T; Ponte M; Leslie K
N Engl J Med; 2007 Sep; 357(13):1352-3. PubMed ID: 17898112
[No Abstract] [Full Text] [Related]
8. Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma.
Tavio M; Vaccher E; Antinori A; Ammassari A; Cusini M; Fasan M; Accurso V; Garavelli LP; Repetto L; Tirelli U
Cancer; 1996 May; 77(10):2117-22. PubMed ID: 8640679
[TBL] [Abstract][Full Text] [Related]
9. [Kaposi's sarcoma].
Imamura A
Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin.
Chagaluka G; Stanley C; Banda K; Depani S; Nijram'madzi J; Katangwe T; Israels T; Bailey S; Mukaka M; Molyneux E
Eur J Cancer; 2014 May; 50(8):1472-81. PubMed ID: 24636877
[TBL] [Abstract][Full Text] [Related]
11. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS
Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
[TBL] [Abstract][Full Text] [Related]
14. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study.
El-Mallawany NK; Kamiyango W; Slone JS; Villiera J; Kovarik CL; Cox CM; Dittmer DP; Ahmed S; Schutze GE; Scheurer ME; Kazembe PN; Mehta PS
PLoS One; 2016; 11(4):e0153335. PubMed ID: 27082863
[TBL] [Abstract][Full Text] [Related]
15. Experience with adriamycin, bleomycin, vincristine (ABV) palliative chemotherapy in advanced AIDS-related Kaposi's sarcoma.
Paparizos VA; Kyriakis KP; Mileounis KA; Pfandl-Polydorou D; Stavrianeas NG; Vareltzidis AG; Stratigos JD
J Chemother; 1996 Oct; 8(5):403-6. PubMed ID: 8957723
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.
Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
Trop Doct; 2008 Jan; 38(1):5-7. PubMed ID: 18302849
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
[TBL] [Abstract][Full Text] [Related]
18. Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; van Dyk U; Stoehr A; Albrecht H; Stellbrink HJ; Berger J; Meigel W
Dermatology; 1997; 194(3):234-7. PubMed ID: 9187839
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma: Good outcome with doxorubicin, bleomycin and vincristine sulphate (ABV) chemotherapy and highly active antiretroviral therapy.
Hesseling PB; Katayi E; Wharin P; Bardin R; Kouya F; Palmer D; Glenn M; Kruger M
S Afr Med J; 2017 Oct; 107(11):952-953. PubMed ID: 29262935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]